Thermo Fisher Scientific Showcases Solutions for Accelerating Next Generation Vaccine and Therapy Research and Unlocking Deeper Analytical Insights

The company announces new mass spectrometry instruments, workflows, software and industry collaborations during ASMS 2022 Conference MINNEAPOLIS–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, is showcasing new instruments, workflows, software and industry collaborations that enable customers to generate new analytical insights and accelerate next generation vaccine and therapy development. The... Read more

Bruker Announces Key Innovations for Highly Multiplexed Spatial Proteomics and Multiomic Tissue Imaging at Large Field-of-View

Fast, large field-of-view MALDI HiPLEX-IHC imaging of targeted proteins, overlaid with unbiased small molecule MALDI Imaging on fresh frozen or FFPE tissues offers compelling innovation for spatial biology and cancer research New microGRID technology for timsTOF fleX platform for MALDI positioning provides virtually artifact-free images across entire slide down to 5 µm SCiLS™ Lab 2023a... Read more

Bruker Introduces Novel Point-of-Need Applied Mass Spectrometry Tools for Accelerated Measurements without Chromatography

Recent acquisition of DART™ (Direct Analysis Real-time Technology) innovator IonSense extends Bruker’s unique Point-of-Need (PoN) mass spectrometers Launch of DART-EVOQ® triple quadrupole mass spectrometer offers simple, robust, yet sensitive and specific PoN workflows for applied markets New Bruker strategic partnership with TOFWERK AG brings together skills and vision for next-generation high-speed, ultra-sensitive analytical solutions MINNEAPOLIS–(BUSINESS... Read more

Bruker Launches timsTOF HT with Greater Dynamic Range for Further Enhancing Unbiased, High-Confidence 4D Proteomics™

4th-generation TIMS XR cell with even greater dynamic range can identify more than 100k unique peptides with 60 min gradients at one microgram protein loads, with high-confidence at 1% FDR and without antigen cross-reactivity Increased dynamic range plus new 14-bit digitizer offer excellent quantitation with <5% protein CVs for many proteins in three-proteome mixture Co-distribution... Read more

GE Healthcare Advances the Future of Precision Medicine in Oncology with New Technology Partners at #ASCO22

Collaborations demonstrate role as a core partner in multidisciplinary cancer care Chicago, US – June 3, 2022: From early detection to remote monitoring and data sharing, GE Healthcare’s innovative suite of diagnostic and treatment technologies are designed to help improve detection, clinical efficiency, operational efficiency, and outcomes for cancer patients. “GE Healthcare is collaborating with health... Read more